Professional Documents
Culture Documents
Researchers Discover How Gum Disease Can Cause Dementia
Researchers Discover How Gum Disease Can Cause Dementia
A team of scientists that includes researchers from Kyushu University and China’s
Beijing Institute of Technology said they have identified how a substance responsible for
causing dementia accumulates in the brain, interfering with memories.
“Our study revealed that periodontal disease bacteria speed up the accumulation of an
abnormal protein in the brain,” said Hiro Take, an associate professor of neuroscience at
Kyushu University. “There is a possibility that treating and preventing this disease may
stop dementia from occurring or progressing.”
Scientists believe Alzheimer’s disease, which accounts for 70 percent of all dementia
cases, occurs and advances when amyloid beta and other anomalous proteins gradually
increase in volume in the brain over the years.
Recent studies have shown that gum disease bacteria and an associated toxic substance
enter the body through blood vessels, leading to the generation and accumulation of
amyloid beta in the brain. But it was not clear how exactly the proteins accumulate
there.
The research team directly administered gum disease bacteria into the abdomens of
mice for three weeks so they would develop the condition. That led the researchers to
compare the infected mice with their healthy counterparts.
The results showed a key receptor protein, which carries amyloid beta into the brain,
had doubled in its amount on the surface of the cerebral blood vessels in the mice with
periodontal disease. The amount of amyloid beta in brain cells rose tenfold as well.
In an experiment that tested their memory, the mice were exposed to electric shocks
when they entered a dark chamber. The healthy mice stayed in a well-lit place for five
minutes. But the infected ones did not wait as long before re-entering the dark room,
waiting just three minutes, indicating that their memory had deteriorated.
The team also administered an agent to inhibit the receptor that brings in amyloid beta.
They discovered the therapy succeeded in reducing the volume of amyloid beta in
infected cells by 40 percent.